- FDA Grants 510(k) Clearance to Curos® Disinfecting Port Protector
Contact: Bob Rogers Chief Executive Officer Ivera Medical Corp. Bob.rogers@iveramed.com 760-612-6090 - Disinfects in 3 minutes and stays clean for up to 7 days - Reduced CLABSI by 86.2 percent and contaminated blood cultures by 92 percent C...
- Ivera Medical Signs New Agreement with Novation for Curos® Port Protectors
Contact: Bob Rogers Chief Executive Officer Ivera Medical Corp. Bob.rogers@iveramed.com 760-612-6090 San Diego, CA., November 28, 2011 Ivera Medical Corporation, a certified minority-owned business, has announced a new agreement with Novatio...
- Ivera Medical Called to Washington to Share Solution for Hospital Acquired Bloodstream Infections
Sr. VP Lloyd Delivers Message to House Veterans’ Affairs Committee: Port Protectors Save Lives and Reduce Costs Contact: Bob Rogers Chief Executive Officer Ivera Medical Corp. 760-612-6090 October 28, 2011, SAN DIEGO, CA--(WIRE)— On Tu...
- Ivera Medical Corporation files suit against Excelsior Medical Corporation for false advertising and unfair competition.
San Diego, CA. September 19, 2011 Ivera Medical Corporation headquartered in San Diego, CA, filed suit in the U.S. District Court, Southern District of California (Civil Case No. 11CV2185 DMS WMC) against Excelsior Medical Corporation of Neptune, NJ...
- Ivera Medical Announces Patent Award for Curos Port Protectors
Patent covers innovative device for blood stream infection prevention San Diego, California, Aug 2, 2011 Ivera Medical Corporation announced today that a United States Patent has been awarded by the U.S. Patent and Trademark to the company for it...
